IRM
Iron Mountain Incorporated (Delaware)Common Stock REIT
Latest News for IRM
Mirum Pharmaceuticals received a Buy rating and an $115.00 price target from J.P. Morgan analyst today. The word on The Street in general, suggests......
Mirum Pharmaceuticals ( ($MIRM) ) just unveiled an announcement. On May 15, 2026, Mirum Pharmaceuticals issued $690 million of 0.00% Convertible Se......
In a report released on May 14, Jonathan Atkin from RBC Capital maintained a Buy rating on Iron Mountain, with a price target of $147.00. The compa......
In a report released today, Mani Foroohar from Leerink Partners maintained a Buy rating on Mirum Pharmaceuticals, with a price target of $154.00. A......
In a report released today, Swayampakula Ramakanth from H.C. Wainwright assigned a Buy rating to Mirum Pharmaceuticals, with a price target of $185......
Jefferies analyst reiterated a Buy rating on Iron Mountain today and set a price target of $148.00. The word on The Street in general, suggests a S......
Jefferies analyst reiterated a Buy rating on Iron Mountain today and set a price target of $148.00. The word on The Street in general, suggests a S......
In a report released today, Lisa Walter from RBC Capital maintained a Buy rating on Mirum Pharmaceuticals, with a price target of $142.00. Accordin......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 15 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRM | $127.33 | +1.2% | 1.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Iron Mountain Incorporated (Delaware)Common Stock REIT Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW